This company was fraudulently claiming that the drug profile of their generics was identical. Thanks to a whistle-blower the company was fined $500m by the FDA, after years of legal wranglings.
More background: https://www.propublica.org/article/fda-let-drugs-approved-on...
This company was fraudulently claiming that the drug profile of their generics was identical. Thanks to a whistle-blower the company was fined $500m by the FDA, after years of legal wranglings.
More background: https://www.propublica.org/article/fda-let-drugs-approved-on...